Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cdb 4124
2. Cdb-4124
3. Cdb4124
4. Proellex
1. Proellex
2. 198414-31-2
3. Telapristone Acetate [usan]
4. 1k9eyk92pq
5. Zpv-200
6. Ru-44675
7. 17alpha-acetoxy-11beta-(4-(dimethylamino)phenyl)-21-methoxy-19-norpregna-4,9-dien-3,20-dione
8. Telapristone Acetate (usan)
9. (8s,11r,13s,14s,17r)-11-(4-(dimethylamino)phenyl)-17-(2-methoxyacetyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl Acetate
10. [(8s,11r,13s,14s,17r)-11-[4-(dimethylamino)phenyl]-17-(2-methoxyacetyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] Acetate
11. Unii-1k9eyk92pq
12. Ccris 9331
13. Cdb 4124
14. Schembl374762
15. Chembl2105694
16. Cdb4124
17. Dtxsid60173587
18. Chebi:188804
19. Telapristone Acetate [who-dd]
20. Db05253
21. D09972
22. Q7695644
23. 11.beta.-(4-(dimethylamino)phenyl)-17-acetoxy-21-methoxy- 19-norpregna-4,9-diene-3,20-dione
24. 19-norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-21-methoxy-, (11.beta.)-
25. 19-norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-21-methoxy-, (11beta)-
| Molecular Weight | 505.6 g/mol |
|---|---|
| Molecular Formula | C31H39NO5 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 505.28282334 g/mol |
| Monoisotopic Mass | 505.28282334 g/mol |
| Topological Polar Surface Area | 72.9 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1020 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For the treatment of uterine fibroids and endometriosis.
Patients receiving Proellex saw improvements in key symptoms associated with uterine fibroids, namely reduced pain and bleeding, as well as effects on bone retention.
Absorption
Orally-available
Proellex selectively blocks the progesterone receptor thus avoiding the adverse effects of GnRH agonists associated with the induction of a low estrogen, menopausal-like state in women.
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Telapristone Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Telapristone Acetate, including repackagers and relabelers. The FDA regulates Telapristone Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Telapristone Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Telapristone Acetate supplier is an individual or a company that provides Telapristone Acetate active pharmaceutical ingredient (API) or Telapristone Acetate finished formulations upon request. The Telapristone Acetate suppliers may include Telapristone Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Telapristone Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Telapristone Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Telapristone Acetate active pharmaceutical ingredient (API) in detail. Different forms of Telapristone Acetate DMFs exist exist since differing nations have different regulations, such as Telapristone Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Telapristone Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Telapristone Acetate USDMF includes data on Telapristone Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Telapristone Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Telapristone Acetate suppliers with USDMF on PharmaCompass.
Telapristone Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Telapristone Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Telapristone Acetate GMP manufacturer or Telapristone Acetate GMP API supplier for your needs.
A Telapristone Acetate CoA (Certificate of Analysis) is a formal document that attests to Telapristone Acetate's compliance with Telapristone Acetate specifications and serves as a tool for batch-level quality control.
Telapristone Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Telapristone Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Telapristone Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Telapristone Acetate EP), Telapristone Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Telapristone Acetate USP).
LOOKING FOR A SUPPLIER?
